LMIM
BHC icon

Lockheed Martin Investment Management’s Bausch Health BHC Stock Holding History

Lockheed Martin Investment Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-15,000
Closed -$239K – 85
2018
Q1 		$239K Buy
+15,000
New +$279K 0.01% 126

Other funds holding BHC

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Lockheed Martin Investment Management's BHC Position: Q2 2018 in Review

Lockheed Martin Investment Management sold out of Bausch Health (BHC) in Q2 2018, closing a stake of 15,000 shares — an estimated $239K sold.

Lockheed Martin Investment Management first reported a position in BHC in Q1 2018 and held it in 1 quarter. The position peaked at $239K in Q1 2018. 311 funds tracked by Wall St. Rank hold BHC as of Q2 2018.

  • Lockheed Martin Investment Management reported no remaining Bausch Health position as of Q2 2018 after selling out during the quarter.
  • Lockheed Martin Investment Management sold 15,000 Bausch Health shares in Q2 2018, an estimated $239K.
  • Lockheed Martin Investment Management first reported a position in Bausch Health in Q1 2018 and held it in 1 quarter.
  • Lockheed Martin Investment Management's Bausch Health position peaked at $239K in Q1 2018.
  • 311 funds tracked by Wall St. Rank held Bausch Health as of Q2 2018.

Based on Lockheed Martin Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.